Newstral
Article
jdsupra.com on 2017-11-21 16:09
Sale of Generic Drug to Physician With “Extensive Information” on the Label May Induce Infringement
Related news
- Judge Stark (D. Del.) Holds Generic Label is Insufficient to Prove Induced Infringementjdsupra.com
- Defendants’ labels induce infringement in this dronedarone casejdsupra.com
- Teva’s Skinny Label Found Not to Induce Infringement by Off-Label Usejdsupra.com
- The Skinny On Induced Infringement And Label Carve-Outsjdsupra.com
- Skinny Labelling on Generic Drugs Does Not Avoid Induced Infringement of Patents Covering Non-Indicated Usesjdsupra.com
- Jury May Infer Intent to Induce Infringement Where Alleged Belief in Noninfringement Is Based on Objectively Unreasonable Reading of Claimsjdsupra.com
- Court Denies Generic Drug Manufacturer’s Motion to Dismiss Hatch-Waxman Patent Infringement Action on Jurisdiction Groundsjdsupra.com
- Patent Infringement Safe Harbor and Importation Redefined: Ruling Incentivizes Generic Pharmaceutical Offshore Product Testingjdsupra.com
- Ineffective Skinny Label Leaves Generic Liable Despite Effort to Carve-Out the Patented Indicationjdsupra.com
- GSK v. Teva: The Skinny On Induced Infringement And Label Carve-Outsjdsupra.com
- Generic Drug Labeling and Induced Patent Infringementjdsupra.com
- Generic Launchesjdsupra.com
- No Induced Infringement Where Off-Label Use of a Drug Is Not “Inevitable” - Takeda Pharms. U.S.A., Inc. v. West-Ward Pharm. Corp.jdsupra.com
- California could launch generic prescription drug labelkentucky.com
- California Could Launch Generic Prescription Drug LabelNBC Bay Area